Validating FFPE-based genomic profiling in pancreatic cancerCommercial NGS panel on routine samples matches TCGA findings and finds actionable targetsINDICATIONPancreaticBIOMARKERKRASRelated casesEvaluating KRAS mutant allele dosage impact on first-line PDAC outcomesAnalyzing specific KRAS variants and treatment outcomes in colorectal cancerCharacterizing KRAS variants in NSCLC with multimodal RWD
